Form 4 Filing for Ives Jeffrey L. - Acumen Pharmaceuticals, Inc.

This filing details transactions by Ives Jeffrey L., a director at Acumen Pharmaceuticals, Inc. (ABOS). On June 3, 2026, Mr. Ives was granted 35,500 shares of Common Stock through a restricted stock unit (RSU) award, which vests fully on the earlier of the first anniversary of the grant date or the 2027 annual stockholder meeting, contingent upon continued service. Additionally, an option to purchase 53,250 shares of Common Stock was granted, also vesting under the same conditions. The exercise price for the stock option is $2.29 per share. Following these transactions, Mr. Ives holds 48,300 shares of Common Stock directly and has options for 53,250 shares.